Another year, another round of approvals, mixed reviews and high-profile failures. We look back on which medicines made the headlines.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
A need for speed: Signals in drug development. Nat Med 18, 1730–1731 (2012). https://doi.org/10.1038/nm1212-1730
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1212-1730